Back to search
FDAFDA · Food and drugs·Recall number F-2400-2014

PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802

Published September 3, 2014 · Recall initiated: June 20, 2013

Summary

FDA records food Class II recall F-2400-2014, published September 3, 2014 and initiated June 20, 2013. Recalling firm: Beta Labs; Status: Terminated; Reported quantity: 743 units; Lot: Lot # 1205129, Exp 12/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beta Labs
Distributor
nationwide and UK
UPC
029882559802
Lot
Lot # 1205129, Exp 12/16
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802 recalled?

Yes. FDA published recall F-2400-2014 on September 3, 2014. Reported hazard: The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 029882559802.